YU142785A - Process for obtaining aromatic 1,4-oxazepinone and thione - Google Patents

Process for obtaining aromatic 1,4-oxazepinone and thione

Info

Publication number
YU142785A
YU142785A YU01427/85A YU142785A YU142785A YU 142785 A YU142785 A YU 142785A YU 01427/85 A YU01427/85 A YU 01427/85A YU 142785 A YU142785 A YU 142785A YU 142785 A YU142785 A YU 142785A
Authority
YU
Yugoslavia
Prior art keywords
oxazepinone
thione
obtaining aromatic
aromatic
obtaining
Prior art date
Application number
YU01427/85A
Other languages
English (en)
Inventor
Y S Lo
A D Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of YU142785A publication Critical patent/YU142785A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
YU01427/85A 1984-09-19 1985-09-11 Process for obtaining aromatic 1,4-oxazepinone and thione YU142785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/652,017 US4610819A (en) 1984-09-19 1984-09-19 Process for the preparation of aromatic-1,4-oxazepinones and thiones

Publications (1)

Publication Number Publication Date
YU142785A true YU142785A (en) 1988-02-29

Family

ID=24615185

Family Applications (2)

Application Number Title Priority Date Filing Date
YU01427/85A YU142785A (en) 1984-09-19 1985-09-11 Process for obtaining aromatic 1,4-oxazepinone and thione
YU01441/87A YU144187A (en) 1984-09-19 1987-07-31 Process for obtaining aromatic 1,4-oxazepinones and thiones

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU01441/87A YU144187A (en) 1984-09-19 1987-07-31 Process for obtaining aromatic 1,4-oxazepinones and thiones

Country Status (20)

Country Link
US (1) US4610819A (xx)
EP (1) EP0175570A3 (xx)
JP (1) JPS6178789A (xx)
KR (1) KR900003852B1 (xx)
AU (2) AU586440B2 (xx)
CA (1) CA1277983C (xx)
DK (1) DK423485A (xx)
ES (1) ES8802305A1 (xx)
FI (1) FI853585L (xx)
GR (1) GR852247B (xx)
HU (2) HU195485B (xx)
IL (1) IL76243A (xx)
IN (1) IN162290B (xx)
NO (1) NO853665L (xx)
NZ (1) NZ213523A (xx)
PH (2) PH22955A (xx)
PL (2) PL150760B1 (xx)
PT (1) PT81157B (xx)
YU (2) YU142785A (xx)
ZA (1) ZA856527B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746655A (en) * 1987-06-10 1988-05-24 A. H. Robins Company, Incorporated Fused aromatic-spiropiperidine oxazepinones(and thiones)
GB8727385D0 (en) * 1987-11-23 1987-12-23 Lundbeck & Co As H Heterocyclic compounds
US11649218B2 (en) 2018-03-09 2023-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794639A (en) * 1966-03-10 1974-02-26 Squibb & Sons Inc Benzoxazepines and benzothiazepines
ZA836994B (en) * 1982-09-30 1984-05-30 Robins Co Inc A H Fused aromatic oxazepinones and sulfur analogs thereof
EP0107930B1 (en) * 1982-09-30 1990-11-28 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Fused aromatic oxazepinones and sulphur analogues thereof and their preparation and use in counteracting histamine

Also Published As

Publication number Publication date
HUT40426A (en) 1986-12-28
KR860002484A (ko) 1986-04-26
IN162290B (xx) 1988-04-23
HU195485B (en) 1988-05-30
ZA856527B (en) 1986-04-30
US4610819A (en) 1986-09-09
FI853585A0 (fi) 1985-09-18
PL255423A1 (en) 1987-05-18
IL76243A0 (en) 1986-01-31
GR852247B (xx) 1986-01-17
PH22955A (en) 1989-02-03
PH23204A (en) 1989-06-06
PT81157A (en) 1985-10-01
DK423485D0 (da) 1985-09-18
NO853665L (no) 1986-03-20
AU4004789A (en) 1989-12-07
PL150760B1 (en) 1990-06-30
EP0175570A3 (en) 1988-07-20
EP0175570A2 (en) 1986-03-26
ES8802305A1 (es) 1987-03-16
CA1277983C (en) 1990-12-18
DK423485A (da) 1986-03-20
KR900003852B1 (ko) 1990-06-02
PT81157B (pt) 1987-10-20
YU144187A (en) 1988-10-31
PL147855B1 (en) 1989-08-31
AU4767385A (en) 1986-03-27
AU586440B2 (en) 1989-07-13
HU194245B (en) 1988-01-28
JPS6178789A (ja) 1986-04-22
NZ213523A (en) 1989-08-29
ES547084A0 (es) 1987-03-16
FI853585L (fi) 1986-03-20
IL76243A (en) 1990-07-26
HUT42070A (en) 1987-06-29

Similar Documents

Publication Publication Date Title
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
GB2159520B (en) 1, 24-dihydroxy- 22-vitamin d3 and process for preparing same
CS78585A2 (en) Zpusob vyroby 1,3 disubstituovanych 2 oxindolu
DE3567638D1 (en) 2,4-dichloro-3-alkyl-6-nitrophenols and process for their preparation
PL264492A1 (en) Method of obtaining 1,2,4,-triazolcarbaminates
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
ZA85575B (en) 1,3,2-dioxaborinanes
GB2162175B (en) 1,8-diacyloxy-10-acylanthrones
YU142785A (en) Process for obtaining aromatic 1,4-oxazepinone and thione
YU167087A (en) Process for obtaining 4,4-dialkyl-2-azetidinone
ZA851236B (en) 2-arylimidazo 4,5-cpyridines
PL255399A1 (en) Method of obtaining 1,3-diacyl-2-ketoindoles
ZA853510B (en) New 2,4-diamino-6-halogeno-5-alkylthio-pyrimidines
GB2156353B (en) 6,6-ethylenedioxy-22r-hydroxy-2r,3s-isopropylidenedioxy-5a-cholest-23-yne
CS219684A1 (en) Sposob pripravy 1 2,6 dimetylfenoxy 2 propylaminu
GB8523735D0 (en) 1,2-benzoxathiine derivatives
CS395284A1 (en) Zpusob vyroby substituovanych benzisothiazolin 3 on 1,1 dioxidu
EP0170822A3 (en) 2,3-dihydrobenzo-4-oxa-thiine
EP0173754A4 (en) 7-THIAPROSTAGLANDINE E1 AND THEIR PRODUCTION.
BG38844A1 (en) Trans- 2- alkylthioureido- 3- hydroxy- 1, 2, 3, 4- tetrahydronaphthalinis, method for their manufacture and use
SU1155596A1 (en) Method of obtaining 1,4-dinitroimidazoles
SU1150248A1 (en) Method of obtaining 2,4-diaminomesitylene-6-sulfoacid
PL249702A1 (en) Method of obtaining 1,2-bis-sililsubstituted ethanes
PL250691A2 (en) Method of obtaining 1,1-dinitroethane
PL245786A2 (en) Method of obtaining 2-methylnaphtoquinone-1,4